Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.

Kesho Bora Study Group, de Vincenzi I.

Lancet Infect Dis. 2011 Mar;11(3):171-80. doi: 10.1016/S1473-3099(10)70288-7. Epub 2011 Jan 13. Erratum in: Lancet Infect Dis. 2011 Mar;11(3):159. Read, Jennifer S [corrected to Read, Jennifer].

PMID:
21237718
2.

Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries?

Coutsoudis A, Coovadia HM, Kindra G.

Bull World Health Organ. 2010 Dec 1;88(12):949-50. doi: 10.2471/BLT.10.076422. No abstract available.

3.

Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.

Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, Kourtis AP, Martinson F, Tegha G, Knight RJ, Ahmed YI, Kamwendo DD, Hoffman IF, Ellington SR, Kacheche Z, Soko A, Wiener JB, Fiscus SA, Kazembe P, Mofolo IA, Chigwenembe M, Sichali DS, van der Horst CM; BAN Study Group.

N Engl J Med. 2010 Jun 17;362(24):2271-81. doi: 10.1056/NEJMoa0911486.

4.

Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.

Six Week Extended-Dose Nevirapine (SWEN) Study Team, Bedri A, Gudetta B, Isehak A, Kumbi S, Lulseged S, Mengistu Y, Bhore AV, Bhosale R, Varadhrajan V, Gupte N, Sastry J, Suryavanshi N, Tripathy S, Mmiro F, Mubiru M, Onyango C, Taylor A, Musoke P, Nakabiito C, Abashawl A, Adamu R, Antelman G, Bollinger RC, Bright P, Chaudhary MA, Coberly J, Guay L, Fowler MG, Gupta A, Hassen E, Jackson JB, Moulton LH, Nayak U, Omer SB, Propper L, Ram M, Rexroad V, Ruff AJ, Shankar A, Zwerski S.

Lancet. 2008 Jul 26;372(9635):300-13. doi: 10.1016/S0140-6736(08)61114-9.

PMID:
18657709
5.

Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.

Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, Mipando L, Nkanaunena K, Mebrahtu T, Bulterys M, Fowler MG, Taha TE.

N Engl J Med. 2008 Jul 10;359(2):119-29. doi: 10.1056/NEJMoa0801941. Epub 2008 Jun 4.

6.

How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa.

Fredlund VG, Nash J.

J Infect Dis. 2007 Dec 1;196 Suppl 3:S469-73. doi: 10.1086/521115. Review.

PMID:
18181696
7.

Low absolute neutrophil counts in African infants.

Kourtis AP, Bramson B, van der Horst C, Kazembe P, Ahmed Y, Chasela C, Hosseinipour M, Knight R, Lugalia L, Tegha G, Joaki G, Jafali R, Jamieson DJ; UNC Project BAN Study Team.

J Int Assoc Physicians AIDS Care (Chic). 2005 Jul;4(3):73-6.

PMID:
16867975
8.

Range of normal neutrophil counts in healthy zimbabwean infants: implications for monitoring antiretroviral drug toxicity.

Wells J, Shetty AK, Stranix L, Falkovitz-Halpern MS, Chipato T, Nyoni N, Mateta P, Maldonado Y.

J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):460-3.

PMID:
16810112
9.

Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.

Grimwade K, Swingler GH.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003508. Review.

PMID:
16437457
10.

Zidovudine plus sulfamethoxazole-trimethoprim adversely affects B lymphocyte maturation in bone marrow of normal mice.

Feola DJ, Garvy BA.

Int Immunopharmacol. 2005 Dec;5(13-14):1881-94. Epub 2005 Jun 29.

PMID:
16275623
11.

The effect of highly active antiretroviral treatment on viral load and antiretroviral drug levels in breast milk.

Colebunders R, Hodossy B, Burger D, Daems T, Roelens K, Coppens M, Van Bulck B, Jacquemyn Y, Van Wijngaerden E, Fransen K.

AIDS. 2005 Nov 4;19(16):1912-5.

PMID:
16227801
12.

Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.

Shapiro RL, Holland DT, Capparelli E, Lockman S, Thior I, Wester C, Stevens L, Peter T, Essex M, Connor JD, Mirochnick M.

J Infect Dis. 2005 Sep 1;192(5):720-7. Epub 2005 Jul 27.

PMID:
16088821
13.

Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.

Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Lishimpi K, Farrelly L, Kaganson N, Zumla A, Gillespie SH, Nunn AJ, Gibb DM; CHAP trial team.

Lancet. 2004 Nov 20-26;364(9448):1865-71.

PMID:
15555666
14.

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.

Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, Kaharuza F, Culver D, Kizito F, Bunnell R, Kigozi A, Nakanjako D, Wafula W, Quick R.

Lancet. 2004 Oct 16-22;364(9443):1428-34.

PMID:
15488218
15.

Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection.

Gill CJ, Sabin LL, Tham J, Hamer DH.

Bull World Health Organ. 2004 Apr;82(4):290-7. Review.

16.

Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months.

Shetty AK, Coovadia HM, Mirochnick MM, Maldonado Y, Mofenson LM, Eshleman SH, Fleming T, Emel L, George K, Katzenstein DA, Wells J, Maponga CC, Mwatha A, Jones SA, Abdool Karim SS, Bassett MT; HIVNET 023 Study Team.

J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):482-90.

PMID:
14657758
17.

Nevirapine use in HIV-1-infected children.

Verweel G, Sharland M, Lyall H, Novelli V, Gibb DM, Dumont G, Ball C, Wilkins E, Walters S, Tudor-Williams G.

AIDS. 2003 Jul 25;17(11):1639-47.

PMID:
12853746
18.

Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.

Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, Ward J.

MMWR CDC Surveill Summ. 1999 Apr 16;48(2):1-22.

PMID:
12412613
19.

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.

Krogstad P, Lee S, Johnson G, Stanley K, McNamara J, Moye J, Jackson JB, Aguayo R, Dieudonne A, Khoury M, Mendez H, Nachman S, Wiznia A; Pediatric AIDS Clinical Trials Group 377 Study Team.

Clin Infect Dis. 2002 Apr 1;34(7):991-1001. Epub 2002 Feb 27.

PMID:
11880966
20.

Supplemental Content

Support Center